Skip to main content
OpenTrials

Clinical trial condition

Herpes Genitalis

Explore clinical trials studying Herpes Genitalis. Study availability and eligibility vary by location and protocol.

53 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Herpes Genitalis trial results

Completed

A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes

NCT06033261

Conditions
Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +14 more
Locations
  • Accel Clinical Sites Network - Cahaba Medical Care Birmingham, Alabama, United States
  • Noble Clinical Research Tucson, Arizona, United States
  • Cedars-Sinai Medical Center/Carbon Health Beverly Hills, California, United States
  • Acclaim Clinical Research San Diego, California, United States
View all 23 locations
View Trial Details
Completed

A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes

NCT06385327

Conditions
Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +14 more
Locations
  • East Sydney Doctors Darlinghurst, New South Wales, Australia
  • Canopy Clinical Sutherland Miranda, New South Wales, Australia
  • Momentum Clinical Research Sydney, New South Wales, Australia
  • Canopy Beaches Clinical Research Sydney, New South Wales, Australia
View all 15 locations
View Trial Details
Completed

A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes

NCT06698575

Conditions
Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +14 more
Locations
  • Alliance for Multispecialty Research Kansas City, Missouri, United States
  • Rochester Clinical Research Rochester, New York, United States
  • Seattle Clinical Research Center Seattle, Washington, United States
  • University of Washington Virology Research Clinic Seattle, Washington, United States
View all 18 locations
View Trial Details
Completed

A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes

NCT05298254

Conditions
Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +17 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Wichita, Kansas, United States
  • GSK Investigational Site Kansas City, Missouri, United States
  • GSK Investigational Site Rochester, New York, United States
View all 30 locations
View Trial Details
Completed

An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

NCT04950712

Conditions
Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +13 more
Locations
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Miami, Florida, United States
View all 51 locations
View Trial Details

Related conditions